JARED MARKS: Open Payments
NPI 1366453177 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,093 in 45 payments from 9 companies in 2025. Trend: 2023 $1,680 · 2024 $1,509 · 2025 $1,093
Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $390 |
| Inspire Medical Systems, Inc. | 10 | $290 |
| GlaxoSmithKline, LLC. | 12 | $151 |
| Integra LifeSciences Corporation | 3 | $102 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Organon LLC | 1 | $33 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: DUPIXENT, INSPIRE, NUCALA, ACCLARENT AERA, TRELEGY ELLIPTA, TEZSPIRE, VTAMA, NEFFY.
Industry payments across TX — which companies pay providers there.
